| Rank | Company | Net assets | Sector | Industry | Country | Exchange |
|---|---|---|---|---|---|---|
| 201 | $604M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 202 | $597M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 203 | $592M | Healthcare | Healthcare Providers | United States | Nasdaq | |
| 204 | $568M | Healthcare | Biotechnology | United States | Nasdaq | |
| 205 | $562M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 206 | $551M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 207 | $540M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 208 | $537M | Healthcare | Healthcare Providers | United States | Nasdaq | |
| 209 | $532M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 210 | $525M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 211 | $524M | Healthcare | Healthcare Providers | United States | Nasdaq | |
| 212 | $524M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 213 | $520M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 214 | $519M | Healthcare | Healthcare Providers | United States | Nasdaq | |
| 215 | $518M | Healthcare | Medical Devices | United States | Nasdaq | |
| 216 | $516M | Healthcare | Medical Devices | United States | Nasdaq | |
| 217 | $516M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 218 | $506M | Healthcare | Medical Instruments & Supplies | United States | NYSE | |
| 219 | $503M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 220 | $491M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 221 | $487M | Healthcare | Biotechnology | United States | Nasdaq | |
| 222 | $485M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 223 | $477M | Healthcare | Healthcare Providers | United States | NYSE | |
| 224 | $474M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 225 | $470M | Healthcare | Healthcare Providers | United States | Nasdaq | |
| 226 | $469M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 227 | $467M | Healthcare | Biotechnology | United States | Nasdaq | |
| 228 | $466M | Healthcare | Health Services | United States | NYSE | |
| 229 | $466M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 230 | $464M | Healthcare | Pharmaceuticals | United States | NYSE | |
| 231 | $462M | Healthcare | Medical Devices | United States | Nasdaq | |
| 232 | $461M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 233 | $456M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 234 | $454M | Healthcare | Biotechnology | United States | Nasdaq | |
| 235 | $454M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 236 | $453M | Healthcare | Healthcare Providers | United States | Nasdaq | |
| 237 | $453M | Healthcare | Biotechnology | United States | Nasdaq | |
| 238 | $452M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 239 | $449M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 240 | $449M | Healthcare | Healthcare Providers | United States | NYSE | |
| 241 | $448M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 242 | $446M | Healthcare | Biotechnology | United States | Nasdaq | |
| 243 | $446M | Healthcare | Medical Devices | United States | NYSE | |
| 244 | $440M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 245 | $440M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 246 | $436M | Healthcare | Biotechnology | United States | Nasdaq | |
| 247 | $434M | Healthcare | Diagnostics & Research | United States | Nasdaq | |
| 248 | $431M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 249 | $429M | Healthcare | Medical Devices | United States | Nasdaq | |
| 250 | $428M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 251 | $426M | Healthcare | Healthcare Providers | United States | Nasdaq | |
| 252 | $425M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 253 | $423M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 254 | $423M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 255 | $421M | Healthcare | Biotechnology | United States | Nasdaq | |
| 256 | $420M | Healthcare | Medical Devices | United States | Nasdaq | |
| 257 | $420M | Healthcare | Biotechnology | United States | NYSE | |
| 258 | $420M | Healthcare | Medical Devices | United States | Nasdaq | |
| 259 | $410M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 260 | $408M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 261 | $408M | Healthcare | Biotechnology | United States | Nasdaq | |
| 262 | $408M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 263 | $408M | Healthcare | Biotechnology | United States | Nasdaq | |
| 264 | $403M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 265 | $398M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 266 | $392M | Healthcare | Medical Instruments & Supplies | United States | NYSE | |
| 267 | $391M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 268 | $387M | Healthcare | Biotechnology | United States | Nasdaq | |
| 269 | $387M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 270 | $385M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 271 | $381M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 272 | $375M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 273 | $374M | Healthcare | Biotechnology | United States | Nasdaq | |
| 274 | $370M | Healthcare | Biotechnology | United States | Nasdaq | |
| 275 | $369M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 276 | $367M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 277 | $365M | Healthcare | Medical Instruments & Supplies | United States | Nasdaq | |
| 278 | $362M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 279 | $359M | Healthcare | Healthcare Providers | United States | Nasdaq | |
| 280 | $356M | Healthcare | Medical Instruments & Supplies | United States | NYSE | |
| 281 | $354M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 282 | $348M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 283 | $348M | Healthcare | Biotechnology | United States | Nasdaq | |
| 284 | $347M | Healthcare | Medical Instruments & Supplies | United States | NYSE | |
| 285 | $347M | Healthcare | Biotechnology | United States | Nasdaq | |
| 286 | $346M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 287 | $344M | Healthcare | Medical Devices | United States | Nasdaq | |
| 288 | $341M | Healthcare | Pharmaceuticals | United States | NYSE | |
| 289 | $340M | Healthcare | Medical Devices | United States | Nasdaq | |
| 290 | $338M | Healthcare | Medical Devices | United States | Nasdaq | |
| 291 | $335M | Healthcare | Medical Instruments & Supplies | United States | Nasdaq | |
| 292 | $332M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 293 | $329M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 294 | $324M | Healthcare | Healthcare Providers | United States | NYSE | |
| 295 | $324M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 296 | $324M | Healthcare | Pharmaceuticals | United States | NYSE | |
| 297 | $323M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 298 | $322M | Healthcare | Medical Instruments & Supplies | United States | Nasdaq | |
| 299 | $322M | Healthcare | Pharmaceuticals | United States | Nasdaq | |
| 300 | $318M | Healthcare | Medical Devices | United States | Nasdaq |